Cancer Archives

cellectis cancer leukemia ucart19 car t cell therapy GOSH baby second biotech

News and Trends 9 May 2016

Universal CAR-T given to Second baby with aggressive Leukemia

Once again, the French biotech Cellectis has hit headlines after having treated a second infant suffering from an aggressive form of Leukemia with their UCART19 therapy. Also based at the famous Great Ormond Street Hospital (GOSH) in London, another child has been treated with the first ever Universal CAR-T cell therapy. The child in question […]

May 9, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 6 May 2016

Biotech of the Week: Affibody and its Super antibodies from Scandinavia

From North Israel, we once again depart North towards Scandinavia to visit Sweden. On one of the several islands that make Stockholm a very particular and special European capital, our Biotech of the week Affibody has its headquarters. City: Stockholm (Sweden) – (actually just down the road from the Karolinska Institute) Founded: 1998 Employees: 22 (as of 11/2015) […]

May 6, 2016 - 2 minutesmins - By Joachim Eeckhout

Epigenomics cancer colorectal china CFDA beijing biochain diagnostic blood test epiprocolon septin9

News and Trends 4 May 2016

‘First Blood Test for Colorectal Cancer is One of the most Innovative Medical Products’ says Chinese FDA

That’s what the China Food and Drug Administration (CFDA) declared on the blood diagnostic test from Berlin-based Epigenomics‘ proprietary Septin9-Biomarker. Their Septin9 test Epi proColon is filling the need for early detection of colorectal cancer. Data show a huge increase in prevalence in urban China.Just last week we interviewed the CEO of Epigenomics, Thomas Taapken, on the company’s Cancer […]

May 4, 2016 - 3 minutesmins - By Dani Bancroft

brain tumor medullablastoma oncurious trial tb 403 neuroblastoma cancer

News and Trends 3 May 2016

Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial

The Belgian biotech startup Oncurious is launching a phase I/IIa trial for an antibody to fight a brain tumor which affects children. Oncurious in Leuven (Belgium) was just launched last April as an emerging oncology company focused orphan drugs for the treatment of pediatric cancers. Its current candidate is preparing for a phase I/IIa trial for the […]

May 3, 2016 - 3 minutesmins - By Dani Bancroft

vatican stem cell research pope biotech biotechnology soon shiong patrick joe biden president

News and Trends 2 May 2016

What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research

Were you aware of the Vatican’s work in the Biosciences – including Biotech? Well, now it has awarded the Richest Doctor in the world, Patrick Soon-Shiong, some fancy award for his pioneering work against Cancer. AND it held an Adult stem cell therapy research conference with the Pope and US Vice President Joe Biden over the weekend. […]

May 2, 2016 - 4 minutesmins - By Dani Bancroft

agendia mammaprint breast cancer metastasis risk

News and Trends 2 May 2016

Genetic Diagnostic can cut number of Breast Cancer Patients needing Chemo in Half

Agendia’s shows remarkable clinical results for its genomic assay (MammaPrint) allowed 48% of early-stage breast cancer patients to be spared from chemotherapy. Agendia started out in 2003 as a spin-off from the Netherlands Cancer Institute to commercialize diagnostic tools for cancer. Its first product was MammaPrint, which uses DNA microarray technology to test the activity 70 genes that […]

May 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

servier lonsurf colorectal cancer trifluridine tipiracil

News and Trends 28 Apr 2016

EU approves Combo-Drug for Metastatic Colorectal Cancer

Servier sees one of its combo-drug (trifluridine/tipiracil) approved by the European Commission, after showing a 2 month improvement in overall survival for metastatic Colorectal cancer. The largest private Pharma from France, Servier has well-known stake in innovative oncology therapies due to its role in the restructuring of Cellectis as a universal CAR-T Biotech – which looks extremely […]

April 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

TC biopharm immunicell melanoma kidney cancer

News and Trends 25 Apr 2016

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

TC BioPharm has began recruitment to a phase II/III trial with its lead candidate (ImmuniCell), a T-cell therapy now targeting skin, lung and kidney cancer. Based in Scotland, TC BioPharm is developing cell-based therapies for cancer and severe viral infection. These therapies are based on γδ T-cells, which can recognise and target specific structures on the cell surface […]

April 25, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 22 Apr 2016

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

We say our goodbyes to Belgium this week and head one more time to Switzerland. In Zürich, where you can find almost any kind of cheese, delicious chocolate and a beautiful view of the Swiss Alps near the city lake, is also where Covagen, our Biotech of the Week is located. City: Zürich (Switzerland) Founded: 2007 Employees: 23 (as of […]

April 22, 2016 - 2 minutesmins - By Joachim Eeckhout

aacr 2016 merus transgene debiopharma innate

News and Trends 21 Apr 2016

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

The annual meeting of the American Association for Cancer Research (AACR) has just finished. From Europe, who made a splash with their results? The AACR annual meeting is the world’s biggest conference in Cancer research, and the must-attend event for Biotechs developing cancer therapies. The 2016 edition took place in New Orleans (US) from the […]

April 21, 2016 - 5 minutesmins - By Denise Neves Gameiro

argenx agx115 abbvie immunooncology biotech deal ucl cancer pharma

News and Trends 21 Apr 2016

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

Ghent based argenx has just partnered up with the French AbbVie to develop a novel antibody derived from llamas – in its biggest deal ever! Having been better known for their work into autoimmune diseases, argenx has now also broken into the Immuno-Oncology field – big time. Previous collaborators have included Denmark’s Leo Pharma for inflammatory […]

April 21, 2016 - 2 minutesmins - By Dani Bancroft

oxford biotherapeutics drug cancer boehringer

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

Boehringer Ingelheim has bought exclusive rights to an oncology target discovered by Oxford BioTherapeutics and its proteomic database. Oxford BioTherapeutics is a Biotech in Milton Park (near Oxford, UK), developing immunotherapies for cancer with antibody-drug conjugates (ADC) – a strategy to combine the specificity of antibodies to a toxic agent that can be delivered to a cancerous cell. […]

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Universal CAR-T given to Second baby with aggressive Leukemia

Biotech of the Week: Affibody and its Super antibodies from Scandinavia

‘First Blood Test for Colorectal Cancer is One of the most Innovative Medical Products’ says Chinese FDA

Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial

What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research

Genetic Diagnostic can cut number of Breast Cancer Patients needing Chemo in Half

EU approves Combo-Drug for Metastatic Colorectal Cancer

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

UK Drug Discovery sells Cancer Target to German Pharma

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!